PDGFRA and tuberous sclerosis: We have previously demonstrated that hyperactivated mTORC1 signaling suppresses the expression of PDGFRα, safeguarding against the development of malignant tumors in tuberous sclerosis complex (TSC), a benign tumor syndrome affecting multiple organs11,23.